Valuation Eli Lilly and Company

Equities

Market Closed - Nyse Other stock markets 01:31:21 19/05/2026 am IST			After hours 05:30:00 am
988.09 ^USD	-1.67%		991.76	+0.37%

19/05	Sector Update: Healthcare Stocks Advance Late Afternoon	MT
19/05	Dell says Eli Lilly scales AI-driven drug discovery & manufacturing with co	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	2,50,419	3,47,613	5,24,224	6,95,134	9,62,248	8,81,121	-	-
Change	-	38.81%	50.81%	32.6%	38.43%	-8.43%	-	-
Enterprise Value (EV) ¹	2,63,395	3,61,640	5,46,522	7,25,355	9,97,483	8,98,503	8,78,047	8,49,026
Change	-	37.3%	51.12%	32.72%	37.52%	-9.92%	-2.28%	-3.31%
P/E ratio	45.1x	53x	101x	65.9x	46.8x	29x	23.5x	19.7x
PBR	29.4x	32.7x	48.9x	49x	36.3x	17.3x	11.3x	7.87x
PEG	-	4.2x	-6.3x	1x	0.5x	0.6x	1x	1x
Capitalization / Revenue	8.84x	12.2x	15.4x	15.4x	14.8x	10.3x	8.99x	7.98x
EV / Revenue	9.3x	12.7x	16x	16.1x	15.3x	10.5x	8.96x	7.68x
EV / EBITDA	26.3x	38.2x	63.7x	45.1x	34.1x	21.7x	17.3x	14.4x
EV / EBIT	31.1x	45.5x	77.4x	50.7x	36.6x	22.1x	18.3x	15.4x
EV / FCF	44.3x	69.1x	690x	193x	111x	43.2x	30.6x	24.3x
FCF Yield	2.26%	1.45%	0.15%	0.52%	0.9%	2.31%	3.26%	4.12%
Dividend per Share ²	3.4	3.92	4.52	5.2	6	6.82	7.529	8.351
Rate of return	1.23%	1.07%	0.78%	0.67%	0.56%	0.69%	0.76%	0.85%
EPS ²	6.12	6.9	5.8	11.71	22.95	34.08	42.1	50.08
Distribution rate	55.6%	56.8%	77.9%	44.4%	26.1%	20%	17.9%	16.7%
Net sales ¹	28,318	28,541	34,124	45,043	65,179	85,399	98,047	1,10,484
EBITDA ¹	10,005	9,472	8,584	16,079	29,271	41,358	50,857	58,876
EBIT ¹	8,457	7,950	7,057	14,313	27,274	40,565	47,955	55,169
Net income ¹	5,582	6,245	5,240	10,590	20,640	30,987	37,835	44,966
Net Debt ¹	12,976	14,027	22,298	30,221	35,235	17,383	-3,073	-32,095
Reference price ²	276.22	365.84	582.92	772.00	1,074.68	988.09	988.09	988.09
Nbr of stocks (in thousands)	9,06,592	9,50,178	8,99,307	9,00,432	8,95,381	8,91,741	-	-
Announcement Date	03/02/22	02/02/23	06/02/24	06/02/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	28.99x	10.52x	21.73x	0.69%	88TCr
JOHNSON & JOHNSON	24.47x	5.64x	15.34x	2.33%	55TCr
ABBVIE INC.	25.49x	6.3x	12.86x	3.28%	37TCr
ROCHE HOLDING AG	17.01x	4.26x	10.49x	3.12%	33TCr
NOVARTIS AG	20.64x	5.54x	13.47x	2.97%	28TCr
ASTRAZENECA PLC	23.12x	4.8x	13.55x	1.82%	28TCr
MERCK & CO., INC.	50.22x	4.67x	19x	2.97%	28TCr
NOVO NORDISK A/S	12.95x	4.76x	9.72x	3.9%	20TCr
AMGEN INC.	21.09x	5.72x	10x	3.11%	18TCr
GILEAD SCIENCES, INC.	-46.86x	5.6x	31.97x	2.5%	16TCr
Average	17.71x	5.78x	15.81x	2.67%	35.1TCr
Weighted average by Cap.	22.55x	6.61x	16.40x	2.29%